2023.03.16 | 4;30 p.m. to 5;30 p.m. | Emotionally Reactive or Highly Avoidant: The Art of Medication Management for Co-occurring Substance Use Disorder and Borderline Personality Disorder in Non-specialty Care Settings
This webinar is aimed at non-specialists and will focus on safe prescribing to those with co-occurring substance use disorder(s) and borderline personality disorder. Dr. Connery is currently co-editing with Lois Choi-Kain, MD, an adaptation of John Gunderson’s evidence-based treatment manual, Good Psychiatric Management, for patients having both borderline personality disorder and alcohol use disorder. This manual will be published by the American Psychiatric Association Press in fall 2024.
- Participants will learn about community prevalence of co-occurring SUD and BPD in non-specialty care settings and how SUD+BPD impacts patient care outcomes
- Participants will learn the most recent evidence-based medication treatments for BPD, with and without SUD, with special considerations for safe prescribing in the context of active SUD and/or elevated suicide risk
- Participants will be provided brief descriptions of evidence-based psychotherapies for SUD+BPD, along with nationally-available resources for referral and patient/family education
Prescribing clinicians and their teams
Hilary S. Connery, MD, PhD Dr. Connery is an assistant professor of psychiatry at Harvard Medical School and serves as the clinical director for McLean Hospital’s Division of Alcohol, Drugs, and Addiction. Dr. Connery’s expertise includes treatment of opioid use disorders and integrated treatments for co-occurring substance use disorders and other mental illnesses. Her current research efforts are directed toward public health prevention strategies for addressing self-injury mortality, and patient-focused investigation regarding suicidal motivations contributing to drug overdose.
Dr. Connery is a distinguished fellow of the American Psychiatric Association and has served within the American Academy of Addiction Psychiatry as New England area director, co-chair of the policy committee, and as a national mentor within the national mentoring program through Providers Clinical Support System. In these roles, she actively advocates for more effective responses to the drug overdose and suicide epidemics, and also nationally mentors clinicians in evidence-based treatment of substance use disorders.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals
- 1 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
- 1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
- 1 contact hour pending for alcohol and drug counselors from the board of alcohol and drug counselors